Introduction

Investment Focus

We invest in drug discovery startups from Japan and Taiwan, as well as in drug candidates being researched and developed by universities, research institutes, pharmaceutical companies, and startups.

Our fund will lead and create a startup company around newly discovered drug candidates that are yet to be developed as part of an enterprise.

Private startups

  • Japan

  • Taiwan

Drug candidates

  • Universities
    Research Institutes

  • Pharma companies
    Startups

Our Strengths

1

Japan's leading sector-specific venture capital fund

Startups, particularly those in capital-intensive fields like drug discovery and regenerative medicine, often struggle to secure sufficient risk capital to support their growth.

We manage the largest fund in Japan to address this need and offer funding solutions.

2

Beyond traditional approaches

Promising drug candidates from universities, research institutes, and pharmaceutical companies are often sidelined due to a lack of resources to develop standalone enterprises around them, despite their high potential.

Our fund establishes startups for these drug candidates, providing the necessary resources to support their development and prevent such setbacks.

3

Hands-on support

In addition to offering risk capital, we provide support for the specialized needs in the pharmaceutical industry, including guidance on clinical development, intellectual property management, regulatory strategy planning, and business development to help startups overcome management challenges.

Fund Details

Accumulated 26.9B JPY in total